Alirinetide

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameAlirinetide
Drug Alias NameGM-6GM-600GM-609GM-608GM-607 +[10] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionHepatocyte growth factor receptor modulatorsInsulin receptor modulatorsPI3-kinase class I modulators
TargetsPI3-kinase class IInsulin receptorHepatocyte growth factor receptor
Therapy Area/IndicationsAmyotrophic Lateral SclerosisStrokeParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGenervon Biopharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenervon Biopharmaceuticals Llc
Active IndicationsN/A
Inactive IndicationsAmyotrophic Lateral SclerosisStrokeParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A